Neutrophil activation in septic acute kidney injury: A post hoc analysis of the FINNAKI study.

Abstract

Inflammation, reflected by high plasma interleukin-6 concentration, is associated with acute kidney injury (AKI) in septic patients. Neutrophil activation has pathophysiological significance in experimental septic AKI. We hypothesized that neutrophil activation is associated with AKI in critically ill sepsis patients. We measured plasma (n=182) and urine (n=118) activin A (a rapidly released cytosolic neutrophil protein), interleukin-8 (a chemotactic factor for neutrophils), myeloperoxidase (a neutrophil biomarker released in tissues), and interleukin-6 on intensive care unit admission (plasma and urine) and 24hours later (plasma) in sepsis patients manifesting their first organ dysfunction between 24hours preceding admission and the second calendar day in intensive care unit. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria. Plasma admission interleukin-8 (240 [60-971] vs 50 [19-164]pg/mL, P<.001) and activin A (845 [554-1895] vs 469 [285-862]pg/mL, P<.001) were but myeloperoxidase (169 [111-300] vs 144 [88-215]ng/mL, P=.059) was not higher among patients with AKI compared with those without. Urine admission interleukin-8 (50.4 [19.8-145.3] vs 9.5 [2.7-28.7]ng/mL, P<.001) and myeloperoxidase (7.7 [1.5-12.6] vs 1.9 [0.4-6.9]ng/mL, P<.001) were but activin A (9.7 [1.4-42.6] vs 4.0 [0.0-33.0]ng/mL, P=.064) was not higher in AKI than non-AKI patients. Urine myeloperoxidase correlated with urine interleukin-8 (R=.627, P<.001) but not with plasma myeloperoxidase (R=.131, P=.158). Interleukin-8 in plasma and urine was associated with septic AKI. Elevated plasma activin A indicates intravascular neutrophil activation in septic AKI. Concomitant plasma and urine myeloperoxidase measurements suggest neutrophil accumulation into injured kidneys.